SCHEMBL24938243

SCHEMBL24938243

COC(=O)CC1N=C(c2ccc(Cl)cc2)c2c(sc(C(N)=O)c2C)-n2c(C)nnc21

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 19/20 0.81
▸ ADORA3 P0DMS8 1/20 0.81
▸ TSPO P30536 1/20 0.81
▸ BRDT Q58F21 7/20 0.72
▸ DNER Q8NFT8 2/20 0.69
▸ BRD2 P25440 4/20 0.69
▸ BRD3 Q15059 3/20 0.67
▸ CREBBP Q92793 2/20 0.67
▸ HDAC3 O15379 1/20 0.67
▸ JAK2 O60674 1/20 0.67
▸ BRD1 O95696 1/20 0.67
▸ CCL2 P13500 1/20 0.67
▸ HDAC4 P56524 1/20 0.67
▸ EP300 Q09472 1/20 0.67
▸ HDAC1 Q13547 1/20 0.67
▸ HDAC7 Q8WUI4 1/20 0.67
▸ HDAC2 Q92769 1/20 0.67
▸ HDAC10 Q969S8 1/20 0.67
▸ HDAC11 Q96DB2 1/20 0.67
▸ HDAC8 Q9BY41 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24391070 1.00 BRD4 (0.81) BRD4ADORA3TSPOBRDTDNER
SCHEMBL2544021 0.92 BRD4 (0.82) BRD4ADORA3TSPOBRDTDNER
SCHEMBL18894409 0.92 BRD4 (0.82) BRD4ADORA3TSPOBRDTDNER
SCHEMBL17884718 0.92 BRD4 (0.82) BRD4ADORA3TSPOBRDTDNER
SCHEMBL21501429 0.92 BRD4 (0.82) BRD4ADORA3TSPOBRDTDNER
SCHEMBL24353326 0.92 BRD4 (0.82) BRD4ADORA3TSPOBRDTDNER
SCHEMBL24391068 0.91 BRD4 (0.83) BRD4ADORA3TSPOBRDTDNER
SCHEMBL24391065 0.90 BRD4 (0.74) BRD4ADORA3TSPOBRDTDNER
SCHEMBL24938238 0.90 BRD4 (0.74) BRD4ADORA3TSPOBRDTDNER
SCHEMBL22917021 0.90 BRD4 (0.78) BRD4ADORA3TSPOBRDTDNER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3256470-B1 METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES DANA FARBER CANCER INST INC (US) 2023-07-26 — — EP disclosed
EP-4119552-A1 REGULATING CHIMERIC ANTIGEN RECEPTORS Dana-Farber Cancer Institute, Inc. (US) 2023-01-18 — — EP disclosed
Send feedback